A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

NCT01688531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne

Interventions

DRUG: CD0271 0.1%/CD1579 2.5% gel
DRUG: CD0271 0.1%/CD1579 2.5% gel vehicle

Sponsor

Galderma R&D